Skip to main content

2 Result(s)

within L. M. Mittlmeier Remove this filter

and

  1. Article

    Open Access

    18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results

    Tyrosine kinase (TKI) and checkpoint inhibitors (CI) prolonged overall survival in metastatic renal cell carcinoma (mRCC). Early prediction of treatment response is highly desirable for the individualization o...

    L. M. Mittlmeier, M. Unterrainer, S. Rodler… in European Journal of Nuclear Medicine and M… (2021)

    Download PDF (2154 KB) View Article

  2. No Access

    Article

    PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma

    L. M. Mittlmeier, M. Unterrainer, A. Todica… in European Journal of Nuclear Medicine and M… (2020)